William Blair Investment Management LLC Reduces Stake in Integer Holdings Co. (NYSE:ITGR)

William Blair Investment Management LLC trimmed its stake in Integer Holdings Co. (NYSE:ITGR) by 37.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 293,267 shares of the medical equipment provider’s stock after selling 174,936 shares during the quarter. William Blair Investment Management LLC owned approximately 0.88% of Integer worth $34,218,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Blue Trust Inc. raised its position in shares of Integer by 483.3% in the fourth quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 377 shares during the period. Principal Securities Inc. bought a new stake in Integer during the 4th quarter worth approximately $67,000. Headlands Technologies LLC bought a new stake in Integer during the 1st quarter worth approximately $106,000. Quadrant Capital Group LLC increased its holdings in Integer by 10.2% during the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock worth $141,000 after acquiring an additional 132 shares during the period. Finally, Strs Ohio increased its holdings in Integer by 54.5% during the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock worth $168,000 after acquiring an additional 600 shares during the period. Institutional investors own 99.29% of the company’s stock.

Analyst Ratings Changes

ITGR has been the topic of a number of analyst reports. Citigroup upped their target price on shares of Integer from $118.00 to $124.00 and gave the stock a “neutral” rating in a report on Wednesday, May 22nd. Oppenheimer initiated coverage on shares of Integer in a report on Tuesday. They set an “outperform” rating and a $135.00 target price on the stock. Truist Financial initiated coverage on shares of Integer in a report on Wednesday, May 15th. They set a “buy” rating and a $137.00 target price on the stock. KeyCorp upped their target price on shares of Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Finally, Bank of America raised shares of Integer from a “neutral” rating to a “buy” rating and increased their price target for the stock from $105.00 to $135.00 in a report on Monday, April 15th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Integer currently has a consensus rating of “Moderate Buy” and a consensus price target of $128.88.

Integer Price Performance

Shares of NYSE:ITGR opened at $124.39 on Thursday. Integer Holdings Co. has a one year low of $69.40 and a one year high of $126.48. The firm has a market capitalization of $4.17 billion, a price-to-earnings ratio of 43.04, a PEG ratio of 1.84 and a beta of 1.11. The company’s fifty day moving average price is $118.00 and its 200-day moving average price is $112.05. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.32 and a quick ratio of 2.01.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. The company had revenue of $414.80 million during the quarter, compared to analysts’ expectations of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. The firm’s revenue was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.87 EPS. On average, equities research analysts anticipate that Integer Holdings Co. will post 5.27 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director James F. Hinrichs sold 9,603 shares of the stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $122.44, for a total value of $1,175,791.32. Following the completion of the transaction, the director now directly owns 7,424 shares in the company, valued at approximately $908,994.56. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director James F. Hinrichs sold 9,603 shares of the stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $122.44, for a total value of $1,175,791.32. Following the completion of the transaction, the director now directly owns 7,424 shares in the company, valued at approximately $908,994.56. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP John A. Harris sold 312 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total transaction of $35,256.00. Following the completion of the transaction, the executive vice president now owns 1,157 shares of the company’s stock, valued at $130,741. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,936 shares of company stock worth $2,130,937. 2.00% of the stock is currently owned by corporate insiders.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.